Blocknomi
Key Takeaways On July 22, 2026, Lakewood-Amedex Biotherapeutics (LABT) announced resistance data for Nu-3, its antimicrobial candidate approaching Phase 2 trials. Serial passage testing demonstrated that Nu-3 does not trigger…
Related articles
-
ZachXBT Sounds Alarm Over AscendEX as Users Struggle to Withdraw Funds
CryptoPotato Published 09.07.2026 21:05
-
USDC issuer Circle wins final approval for US national trust bank charter
Cointelegraph Published 10.07.2026 11:37
-
Ethereum Price Prediction: Arthur Hayes Makes $25M Move as ETH Tests $2K
Cryptonews Published 21.07.2026 10:04
-
Bitfufu Reports June 2026 Bitcoin Production and Hashrate Metrics
Bitcoin.com Published 12.07.2026 08:30
-
Jim Cramer Calls the Market ‘Miserable’ as Oil, Tariffs, and Fed Hawkishness Rattle Wall Street
Bitcoin.com Published 21.07.2026 11:30
-
China’s Moonshot Reportedly Stole U.S. AI Tech for Kimi K3
BeInCrypto Published 22.07.2026 14:31
-
Hyperliquid sets 500,000 HYPE stake for permissionless prediction market deployers
Cointelegraph Published 20.07.2026 12:20
-
Grayscale’s 0.15% Ethereum Mini Trust Fee Turns ETF Competition Into A Price Fight
NewsBTC Published 09.07.2026 11:40